Methadone Market - Growth Drivers and Challenges
Growth Drivers
- Increasing Application in Heroin Addiction Treatment – Methadone is widely used to reduce addiction or dependency on heroin, morphine, or prescription painkillers. Therefore, increasing application in heroin addiction treatment is one of the growth drivers of this market. As per the latest World Drug Report, every year around 35 million people suffer from Drug disorders.
- Increasing Geriatric Population – As discussed in the above parts, methadone is a drug or medication that helps in reducing pain after a post-surgery or therapeutic treatment. Also, the medication patients recover from any kind of chronic disease if they are suffering through it. Many times it is seen that people who are above the age of 60 or who belong to the geriatric population end up suffering from chronic disease. Therefore, the increasing geriatric population is driving the growth of this market. As per a report from the World Health Organization, the geriatric population is expected to become double.
- Growing Development and Launches in the Field of Methadone – Recently, lots of development and launch have taken place in the field of methadone. Elite Pharmaceutical and Glenmark Pharmaceutical collaborated and introduced methadone hydrochloride tablets in the market that will be used to reduce opioid abuse in patients.
- Growing Existence of Chronic Diseases – In the United States around 45% population of the region suffers from chronic diseases.
Challenges
- Side Effects of Methadone – The rise in side effects, such as constipation, nausea, and vomiting, among others, is one of the factors that is expected to restrict the expansion of the methadone market. Furthermore, the market is likely to face obstacles because of strict government approval.
- Addictive Nature of Opioids
- Circulation of Generic Methadone
Methadone Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Year |
2026-2035 |
|
CAGR |
7.4% |
|
Base Year Market Size (2025) |
USD 193.93 million |
|
Forecast Year Market Size (2035) |
USD 395.99 million |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of methadone is assessed at USD 206.85 million.
The global methadone market size was valued at more than USD 193.93 million in 2025 and is expected to register a CAGR of over 7.4%, exceeding USD 395.99 million revenue by 2035.
North America methadone market is projected to secure a 42% revenue share, spurred by the rising incidence of drug addiction and the growing reliance on methadone for managing post-operative and substance-related pain.
Key players in the market include Eli Lilly and Company, Sanofi S.A., Hikma Labs Inc., Mallinckrodt Pharmaceuticals, Siegfried Holding AG, Johnson Matthey, Gilead Sciences, Inc., BioControl Medical, Tianjin Central Pharmaceutical Industry Co., Ltd.
